Hapharm Group Co.,Ltd.’s Net Profit Rose 76% in First Three Quarters of 2023

Hapharm Group Co.,Ltd. (哈药集团股份有限公司) (600664.SH) reported a net profit of 348.2 million yuan in the first three quarters of 2023, up 76% year-on-year.

Meanwhile, the company posted 11.5 billion yuan in revenue, up 15% year-on-year.

At the end of the reporting period, it had 13.9 billion yuan in total assets and 8.6 billion yuan in total liabilities, with a liability-to-asset ratio of 61.9%.